Rankia Colombia
Acceder
¿Nos visitas desde USA? Entra a tu página Rankia.us.

Foro de Bolsa > Farmas USA

SGMO b2k la valora en $8.5 ahora: "There is still a lot to value with SGMO.

<< Volver al mensaje 'SGMO b2k la valora en $8.5 ahora: "There is still a lot to value with SGMO.'

Investing_saints
#113425

Re: Farmas USA

SGMO

b2k la valora en $8.5 ahora:

"There is still a lot to value with SGMO. Even without the gene editing, it can still do all that the CRISPR companies can do. It has Hemophilia A in partnership with PFE, it has Hemoglobinopathies with Bioverativ, and they have the whole CAR-T program for GILD.

They have $380 million in cash. 

I would value the pipeline at $500 million for a company at this stage of development with it potential. That would put the new fair value at $880 million or $8.50 per share. It looks cheap today, but I agree with Harry that you have to let it shake out. I think it could technically get driven to $5 before it bottoms."

--

Perdonad tantos mensajes seguidos pero creo que es información interesante...

<< Volver al mensaje 'SGMO b2k la valora en $8.5 ahora: "There is still a lot to value with SGMO.'

¿Cuál es mi broker ideal?

Brokers destacados